Back to Search
Start Over
Is gene therapy ready for HIV/Ebola virus-derived viral vectors?
- Source :
-
Lancet . 3/10/2001, Vol. 357 Issue 9258, p776. 3/5p. 1 Color Photograph. - Publication Year :
- 2001
-
Abstract
- Focuses on the development of an HIV-based viral vector EboZ, that carries envelope proteins from the Zaire strain of Ebola virus. Role of James Wilson, who is the director of the Institute of Gene Therapy at the University of Pennsylvania, and is connected to the death of Jesse Gelsinger; Purpose of the vector for the treatment of cystic fibrosis; Success of the treatment in causing the transduction of tracheal epithelial cells; Warnings regarding the safety of the treatment.
- Subjects :
- *GENE therapy
*CYSTIC fibrosis
*EBOLA virus
Subjects
Details
- Language :
- English
- ISSN :
- 01406736
- Volume :
- 357
- Issue :
- 9258
- Database :
- Academic Search Index
- Journal :
- Lancet
- Publication Type :
- Academic Journal
- Accession number :
- 4170282
- Full Text :
- https://doi.org/10.1016/S0140-6736(05)71205-8